Mina Sooch

Mina Sooch

Company: Ocuphire

Job title: Chief Executive Officer


APX3330, An Oral Tablet for Treatment of Diabetic Retinopathy 5:00 pm

Ref-1, Novel target for retinal diseases Safety data across 11 Phase 1 and Phase 2 clinical trials Ongoing clinical trial designRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.